|
|
| (142 intermediate revisions not shown) |
| Line 1: |
Line 1: |
| | __NOTOC__ | | __NOTOC__ |
| - | {{Team:Aachen/SlimHeader}} | + | {{Team:Aachen/Header}} |
| - | {{Template:Team:Aachen/Scripts}}
| + | |
| | {{Template:Team:Aachen/Stylesheet}} | | {{Template:Team:Aachen/Stylesheet}} |
| - | <html><link href="https://2014.igem.org/Template:Team:Aachen/Scripts/jquery.skitter.styles?action=raw&ctype=text/css" type="text/css" media="all" rel="stylesheet" />
| + | = Blog #21 - iGEM Meetup Last Weekend - A Great Success! = |
| - | <script type="text/javascript" src="https://2014.igem.org/Template:Team:Aachen/Scripts/jquery-1.6.3.min?action=raw&ctype=text/javascript"></script>
| + | by [[User:Nbailly|Nina]] 09:27, 16 September 2014 (CDT) |
| - | <script type="text/javascript" src="https://2014.igem.org/Template:Team:Aachen/Scripts/jquery.easing.1.3?action=raw&ctype=text/javascript"></script>
| + | |
| - | <script type="text/javascript" src="https://2014.igem.org/Template:Team:Aachen/Scripts/jquery.skitter.min?action=raw&ctype=text/javascript"></script>
| + | |
| - | </html>
| + | |
| | | | |
| - | = Blog #19 - Open Hardware at the Maker Faire Hannover = | + | {{Team:Aachen/FigureFloat|Aachen_IGEM_Aachen_Meetup_Gruppenbild_3.jpg|title=Group Picture|subtitle=A final group picture taken by Carsten Ludwig from team Braunschweig.|left|width=500px}} |
| - | [[User:Mosthege|Michael]] 03:55, 6 July 2014 (CDT)
| + | |
| | | | |
| - | This weekend [[User:fgohr|Florian]], [[User:R.hanke|René]] and [[User:mosthege|Michael]] joined [[User:Ansgar|Ansgar]] on a trip to the [http://makerfairehannover.com/ Maker Faire Hannover 2014].
| + | Last weekend, six iGEM teams from all over Germany – namely Braunschweig, Darmstadt, Bielefeld, Tübingen, Freiburg and Munich – met with our team in Aachen. |
| | | | |
| - | The Maker Faire is an exhibition with things that people built on their own using readily available tools. Dozens of 3D printers and microcontrollers can be examined and there are a lot of devices visitors can interact with. | + | The weekend started with a welcome ceremony for all iGEM teams in the Couven hall on our RWTH campus. After our Jeopardy battle, the teams from Bielefeld, Darmstand, Braunschweig, Tübingen, Munich and Aachen presented their project ideas in 15-minute talks to the public audience. [https://2014.igem.org/Team:Aachen/Blog/14-09-16-01 Read more...] |
| - | Apart from the fire-spitting dragon, our OD and fluorescence measurement devices attracted a lot of attention. We spoke with hundreds of visitors and had a lot of interesting conversations.
| + | |
| | | | |
| - | Saturday evening, Carsten Ludwig from the [[Team:Braunschweig|iGEM Team Braunschweig]] visited us. We showed him the most fascinating stands and afterwards went to the city to walk the [http://www.roterfaden-hannover.de/ ''Red Thread of Hannover''], a track going past 36 very central tourist attractions as e.g. the roofless church:
| + | For a German version of this blog entry, please click [https://2014.igem.org/Team:Aachen/Blog/14-09-16-02 here]. |
| | | | |
| - | On this quick sightseeing trip we took a nice [[Media:Aachen_MakerFairePanorama.jpg|panorama of the ''Aegidienkirche'']].
| |
| - | <br/>
| |
| - | <center>
| |
| - | <html><iframe frameborder="0" src="http://photosynth.net/embed.aspx?cid=561cee62-8a5a-49df-8167-85e3c6be0590&delayLoad=true&slideShowPlaying=false" width="500" height="300"></iframe></html>
| |
| - | </center>
| |
| - | <br/>
| |
| | | | |
| - | When the #NEDCRC soccer game started, we settled for some hamburgers, fermentation broth and exchanged funny stories about our lab experience.
| + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| - | On Saturday the run on our stand had been so enormous that we had to improvise and print new flyers at our hostel for Sunday, the second and last day of the fair. Just like the day before, a lot of people showed interest in our stand and especially René passionately demonstrated our devices and informed about synthetic biology as well as our project "Cellock Holmes".
| + | = Blog #20 - Won a gene synthesis from Eurofins = |
| | + | by [[User:Mosthege|Michael]] 03:25, 18 July 2014 (CDT) |
| | | | |
| - | At about midday, Manuel, advisor of [[Team:Bielefeld-CeBiTec|Team Bielefeld]], visited us and got to experience our measurement device too.
| + | Two weeks ago we had an email in our inbox that made us very happy: We had won a gene synthesis from [http://eurofinsgenomics.eu/en/eurofins-genomics/corporate-information/deals-promotions/igem-sponsorship.aspx Eurofins Genomics]! |
| | | | |
| - | When we left Hannover Monday morning, we decided to stop by in Bielefeld to meet the rest of their team. This way they too got to test our OD and fluorescence measurement device and we got to eat some ''delicious'' ribes cake :)
| + | On Wednesday, we were then visited by Ms. Blumstein who handed us the voucher. Then we took this beautiful photo: |
| | | | |
| - | Five hours later, we left the Bielefeld team to eat some incredibly spicy pizza and continue our journey back home to Aachen. On the Autobahn we took the time to write down all experiences and things we learned to share them with our team in the coming days.
| + | [[Image:Aachen_14-07-16_GruppenbildEurofins.jpg|center|300px]] |
| | | | |
| - | '''tl;dr:''' We had an awesome trip to the Maker Faire Hannover, presented our devices to hundreds of people and met the teams Braunschweig and Bielefeld.
| |
| | | | |
| - | <br/>
| + | {{Team:Aachen/BlockSeparator}} |
| - | <center>
| + | |
| - | '''If you like to see more about our weekend have a look at the following gallery =)'''
| + | |
| | | | |
| | + | = Blog #19 - Noneffective Antibiotics (Part III): Have the Pharma Giants Lost The Race?= |
| | | | |
| - | <gallery mode=packed| caption="iGEM Team Aaachen going to MakerFaire and making new friends">
| + | By [[User:NBailly|NBailly]] 15:39, July 15 2014 (CDT) |
| | | | |
| - | File:Aachen_MakerFaire_01.JPG|Trying to squeeze everything into the much too small trunk...
| + | {{Team:Aachen/FigureFloat|Aachen_David-Goliath-S1-300x261.jpg|left|width=300px|title=David and Goliath|subtitle=Small Companies have taken leading position in antibiotics research. Picture by LegalIT Lawyers.}} |
| - | File:Aachen_MakerFaire_02.JPG|''Hmm... how does that work?''
| + | <html>It is not the big pharma companies that will develop the desperately needed new generation of antibiotics that can even cope with multi-resistant bacteria such as MRSA. Instead, some smaller companies who never gave up researching this field are now future market leaders. As the German business news magazine <a href="http://www.wiwo.de/technologie/forschung/wirkungslose-antibiotika-krankenhaeuser-als-sammelbecken-von-multiresistenten-keimen/10076108-2.html">Wirtschaftswoche</a> reported this June, it is companies like the British-Swedish Astra Zeneca or Hoffmann-La Roche spin off Basilea that are now in a leading position.</html> |
| - | File:Aachen_MakerFaire_03.JPG|Finally! Let's go to Hannover!
| + | [https://2014.igem.org/Team:Aachen/Blog/14-07-15-01 Read more...] |
| - | File:Aachen_MakerFaire_04.jpg|Getting close to our destination
| + | |
| - | File:Aachen_MakerFaire_05.jpg|After a little traffic jam we made it to the '''MakerFaire'''
| + | |
| - | File:Aachen_MakerFaire_06.JPG|Florian ready to "Make Light"!
| + | |
| - | File:Aachen_MakerFaire_07.JPG|Some last preparations...
| + | |
| - | File:Aachen_MakerFaire_08.JPG|''The Visitation of Smaug''
| + | |
| - | File:Aachen_MakerFaire_09.jpg|Enthusing future Nobel Prize laureate with Synthetic Biology and Open Hardware
| + | |
| - | File:Aachen_MakerFaire_10.jpg|Caught the attention of VDI (''The Association of German Engineers'')
| + | |
| - | File:Aachen_MakerFaire_11.jpg|''Am I going to become a TV star?''
| + | |
| - | File:Aachen_MakerFaire_12.jpg|Trying to hold back stage fright
| + | |
| - | File:Aachen_MakerFaire_13.jpg|Carsten from [[Team:Braunschweig|iGEM Team Braunschweig]] arrived and burns with desire to get to know our devices ;)
| + | |
| - | File:Aachen_MakerFaire_14.jpg|[[Team:Aachen|''Aachen'']] and [[Team:Braunschweig|''Braunschweig'']] exploring [[Team:Hannover|''Hannover'']]
| + | |
| - | File:Aachen_MakerFaire_15.jpg|Sadly, every evening comes to an end... Thanks to Carsten for visiting us at the MakerFaire and spending the evening together! =)
| + | |
| - | File:Aachen_MakerFaire_16.jpg|Arranging the new nightly printed flyers
| + | |
| - | File:Aachen_MakerFaire_17.jpg|The left device measures the fluorescence of riboflavin. Can you guess what we have used to demonstrate our OD measurement device at the right? ;)
| + | |
| - | File:Aachen_MakerFaire_18.jpg|Manuel, advisor of [[Team:Bielefeld-CeBiTec|iGEM Team Bielefeld]] having a close look at our devices
| + | |
| - | File:Aachen_MakerFaire_19.jpg|Promising frist contact with [[Team:Bielefeld-CeBiTec|iGEM Team Bielefeld]]
| + | |
| - | File:Aachen_MakerFaire_20.jpg|Florian controling this childrens' game only with the strenght of his mind
| + | |
| - | File:Aachen_MakerFaire_21.jpg|A well deserved rest playing some table teris
| + | |
| - | File:Aachen_MakerFaire_22.jpg|Still in presentation mode demonstrating our fluorescence device to [[Team:Bielefeld-CeBiTec|iGEM Team Bielefeld]]
| + | |
| - | File:Aachen_MakerFaire_23.jpg|Fascination of technology
| + | |
| - | File:Aachen_MakerFaire_24.jpg|After enjoying delicious cake and having interesting conversations with the [[Team:Bielefeld-CeBiTec|iGEM Team Bielefeld]] one last picture before heading back home...
| + | |
| | | | |
| - | </gallery>
| |
| - | </center>
| |
| | | | |
| - | = Blog #18 - iGEM team at RWTH Open House =
| + | {{Team:Aachen/BlockSeparator}} |
| - | By [[User:NBailly|NBailly]] 15:22, June 29 2014 (CDT)
| + | |
| | | | |
| - | <html>Yesterday, RWTH organized an <a href="http://www.rwth-aachen.de/cms/root/Studium/Vor_dem_Studium/Liste/~tfg/ErstInfoTag-Entdecke-die-Welt-des-Studi/">open house</a> for students from ages 14 to 16. Different departments, institutes and student councils presented exhibits, latest research projects, and the many programs they offer. Students could actively try out science and research in prepared experiments at each stand. Various groups of student representatives also offered first hand advice to students with respect to what to study and when and where to collect information. In presentations about the different fields of studies, students gained first insights into the world of academic professions and other career perspectives.</html>
| + | = Blog #18 - Noneffective Antibiotics (Part II): Hospitals as Receptacles for Multi-Resistant Pathogens = |
| | + | By [[User:NBailly|NBailly]] 17:21, July 14 2014 (CDT) |
| | | | |
| | + | {{Team:Aachen/FigureFloat|Aachen_mrsa.jpg|width=200px|left|title=SEM of a human immune cell ingesting MRSA|subtitle=Picture by NIAID.}} |
| | + | <html>In their article <a href="http://www.wiwo.de/technologie/forschung/wirkungslose-antibiotika-krankenhaeuser-als-sammelbecken-von-multiresistenten-keimen/10076108-2.html">Noneffective Antibiotics</a> published in June, the German business news magazine Wirtschaftswoche explains it as follows: Antibiotics are the natural weapon of molds or soil microbes against competing bacterial growth. These bacteria under siege in turn counterattack with resistances: attack and defense – the natural course of evolution. Thus it was only natural, too, that since the first human use of penicillin and co., pathogens have developed strategies in order to escape the antibiotics’ effect albeit these drugs are quite insidious weapons.</html> [https://2014.igem.org/Team:Aachen/Blog/14-07-14-01 Read more...] |
| | | | |
| - | <html><a style="text-align: center; display: block;" href="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/06/14-06-28-Erstinfotag-2.jpg"><img src="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/06/14-06-28-Erstinfotag-2-1024x768.jpg" alt="Nina and Florian showed students how they can get involved in research outside of the programs." width="590" height="442" class="size-large wp-image-285" /><figcaption>Nina and Florian showed students how they can get involved in research outside of the programs.</figcaption></a></html>
| |
| | | | |
| | + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| - | Our iGEM team, too, supported the bioscience department with our own stand. We presented a prototype of our measurement device <em>Cellock Holmes</em> that students could use to measure the fluorescence of different riboflavin solutions. Apart from giving general advice as university students to high school students, Nina and Florian explained students how they can get involved in research outside of a specific university program.
| + | = Blog #17 - Open Hardware at the Maker Faire Hannover = |
| | + | [[User:Mosthege|Michael]] 03:55, 6 July 2014 (CDT) |
| | | | |
| - | = Blog #17 - Noneffective Antibiotics (Part III): Companies are Looking for Microbiologists =
| + | This weekend [[User:fgohr|Florian]], [[User:R.hanke|René]] and [[User:mosthege|Michael]] joined [[User:Ansgar|Ansgar]] on a trip to the [http://makerfairehannover.com/ Maker Faire Hannover 2014]. |
| - | By [[User:NBailly|NBailly]] 15:39, June 25 2014 (CDT)
| + | |
| | | | |
| - | The British-Swedish company Astra Zeneca is in a leading position. In 2012, it brought the first resistance crusher, Ceftarolin, to the European market. This drug can also cope with MRSA. Astra Zenaca, among other few pharma companies, had never given up on antibiotics research. “We have maintained our long-standing expertise of our researchers and developers on this field”, Christian Kreher says happily, who is responsible for the drug group in Germany. | + | The Maker Faire is an exhibition with things that people built on their own using readily available tools. Dozens of 3D printers and microcontrollers can be examined and there are a lot of devices visitors can interact with. |
| | + | Apart from the fire-spitting dragon, our OD and fluorescence measurement devices attracted a lot of attention. We spoke with hundreds of visitors and had a lot of interesting conversations. [https://2014.igem.org/Team:Aachen/Blog/14-07-06-01 Read more...] |
| | | | |
| - | Competitors, on the one hand, admit how laborious it is to still find good microbes. On the other hand, Astra Zeneca even increased its department in 2009. The corporation bought the French Novexel for 400 million dollars. There Sanofi had spun off its antibiotic research department. This way the drug pipeline of researchers from Höchst, too, ended up with the competitor Astra Zeneca.
| |
| | | | |
| - | Among the latter is another highly interesting resistance remedy of the latest generation, called Avibactam. It was combined by the Astra Zeneca developers with a classic broad-spectrum ingredient of the class cephalosporins, which rip holes into cell walls. The combined medicament is running through the last two phases of authorizing trials on humans.
| + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| - | The highlight of “Avi”, how expert Kreher lovingly calls his biological crowbar: It tricks persistent multi-resistant bacteria by suspending their defense against cephalosporin. This works with almost all bacteria that infect the human body. If everything works Astra Zeneca want to admit the combined drug treatment to urinary tract infections and pneumonia in 2016.
| + | = Blog #16 - iGEM team at RWTH Open House = |
| | + | By [[User:NBailly|NBailly]] 15:22, June 29 2014 (CDT) |
| | | | |
| - | This success should sadden Sanofi researchers as well as their colleagues at the Swiss Roche and Novartis or at Bayer in Leverkusen: Years ago, they all gave up on numerous promising ideas. The at that time spun off companies Basilea in Basel, Nabriva in Vienna and Aicuris in Wuppertal now cheerfully keep on developing the concepts.
| + | {{Team:Aachen/FigureFloat|Aachen_14-06-28_Erstinfotag_(2).JPG|left|width=300px|title=Our iGEM stand|subtitle=[[User:NBailly|Nina]] and [[User:fgohr|Florian]] showed students how they can get involved in research outside of the programs..}} |
| | + | <html>Yesterday, RWTH organized an <a href="http://www.rwth-aachen.de/cms/root/Studium/Vor_dem_Studium/Liste/~tfg/ErstInfoTag-Entdecke-die-Welt-des-Studi/">open house</a> for students from ages 14 to 16. Different departments, institutes and student councils presented exhibits, latest research projects, and the many programs they offer. Students could actively try out science and research in prepared experiments at each stand. Various groups of student representatives also offered first hand advice to students with respect to what to study and when and where to collect information. In presentations about the different fields of studies, students gained first insights into the world of academic professions and other career perspectives.</html> [https://2014.igem.org/Team:Aachen/Blog/14-06-29-01 Read more...] |
| | | | |
| - | Since 2013, for example, Basilae has approval for Ceftobiprol, fifth generation cephalosporin. The special thing about it: the drug has been optimized in the lab for so long until it could cope with a multitude of killer germs at the same time. Ceftobiprol should manage them all, Basilea’s head of development Achim Kaufhold assures.
| |
| - |
| |
| - | So far the innovative medicament has been admitted to help people with severe pneumonia. Since in these cases special regulations for premature stops of the therapy exist, Kaufhold could negotiate a for his company very attractive – namely a high – price with the health insurance companies. He does not want to specify any numbers but analysts estimate that the new antibiotic will yield more than one billion dollars on the market. “You really can make a lot of money will modern antibiotics”, Kaufhold, at least, is convinced.
| |
| - |
| |
| - |
| |
| - | <html><em>A translation of <a href="http://www.wiwo.de/technologie/forschung/wirkungslose-antibiotika-gefaehrlicher-kampf-gegen-killerkeime/10076108.html" target="_blank">"Wirkungslose Antibiotika"</a> published in WirtschaftsWoche on June 23rd, 2014.</em></html>
| |
| - |
| |
| - |
| |
| - | = Blog #16 - Noneffective Antibiotics (Part II): Hospitals as Receptacles for Multi-Resistant Pathogens =
| |
| - | By [[User:NBailly|NBailly]] 17:21, June 24 2014 (CDT)
| |
| - |
| |
| - | Attack and defense: that is the natural course of evolution – also in the battle between germs and drugs. Since the early days of penicillin and co. at the beginning of the 20th century, pathogens have developed strategies in order escape the antibiotics’ effect. Most antibiotics stem from molds or soil microbes that defend themselves against annoying competitors. The bacteria under siege, on the other hand, counterattack with resistances.
| |
| - |
| |
| - | Antibiotics are insidious weapons: sometimes they rip holes in the cell walls of growing bacteria. Sometimes they prevent that germs secrete harmful substances which in turn kills them. Or they block the unwinding of the DNA strand so that its information cannot be read anymore. To stop the production of protein is also a strategy to hinder bacterial growth. As long as a pathogen only carries resistances against one or two of these mechanisms, it can still be attacked with a third or fourth dual mode of action. The situation just became problematic when multi-resistant germs arose: They had developed so many defense strategies that none of the hundreds of antibiotics was still effective.
| |
| - |
| |
| - | Meanwhile the situation is precarious: In Europe alone about 25,000 people fall victim to multi-resistant pathogens year in and year out. Especially in hospitals, for example, when receiving an artificial hip joint, the danger to get infected with one of the main malefactors is great: the methicillin resistant Staphylococcus aureus, MRSA for short. It causes wound and abdomen infections, sepsis and pneumonia.
| |
| - |
| |
| - | And even who survives a resistant germ is often hospitalized for a long time and causes on average 4,000 euros additional costs in Germany. With respect to the European Union, that adds up, including the productivity loss, to about 1.5 million euros economic damage per year.
| |
| - |
| |
| - |
| |
| - | <html><div style="border: 1px solid black; padding: 1px;">
| |
| - |
| |
| - | <strong>Problems in Hospitals</strong>
| |
| - | </br></br>
| |
| - | <em>These germs are difficult to combat</em></br>
| |
| - | Around three to five percent of hospital germs are strain of the multi-resistant Staphylococcus aureus (MRSA) that lives on skin and mucosa, against which still four to five effective antibiotics exist. On the contrary, other, intestinal bacteria (ESBL) produce specific enzymes that make them resistant against most classes of antibiotics. Especially difficult to treat are infections with KPC (carbapenemase producing bacteria of the type Klebsiella pneumoniae), because in this case, too, the carbapenemes, the last new active ingredients, fail and doctors have to switch to an out-dated antibiotic. The development of new antibiotics is lagging behind.
| |
| - | </br></br>
| |
| - | <em>When do antibiotics fail?</em></br>
| |
| - | About 90 percent of hospital-acquired infections come from germs that can be combated effectively with one antibiotic. More problematic are the pathogens that have developed resistances. Presumably, this is happens because, among other things, antibiotics are used too often in animal feed, but also with humans, and are administered not well-directed. Thereby, antibiotic-sensitive bacteria are killed while antibiotic-resistant bacteria can proliferate with even less competition.
| |
| - | </br></br>
| |
| - | <em>When does it get dangerous?</em></br>
| |
| - | The majority of pathogens that are responsible for infections in hospitals, usually are harmless bacteria that populate many people. However, if these, usually intestinal, bacteria get into the blood stream, bladder or lung, they can become a danger, particularly for immune deficient people.
| |
| - | </div></html>
| |
| - |
| |
| - |
| |
| - | The problem is mostly home-made, because we downright breed such resistances through the use of antibiotics with humans and animals.
| |
| - |
| |
| - | A series of provisions could at least prevent that the process gains momentum and that new super bugs arise more quickly than researchers can develop new antibiotics.
| |
| - |
| |
| - | After decades of slack, in which one single really new substance class with an innovative mechanism of action was brought on the market, the antibiotics research has finally come into motion again. Researchers today do not want to develop a steam roller as big as possible, that floor all kinds of bacteria, anymore. Instead, they are now looking for active ingredients that break resistances with targeted strikes.
| |
| - |
| |
| - | According to Martin Blaser, this would also have another, totally different – and very positive – effect. It would lead to that we are not continuously maltreating our own, helpful bacteria, for example, in our gut. “This leads to sequential damage that we have not even anticipated yet”, the New York researcher warns.
| |
| - |
| |
| - |
| |
| - | <html><em>A translation of <a href="http://www.wiwo.de/technologie/forschung/wirkungslose-antibiotika-gefaehrlicher-kampf-gegen-killerkeime/10076108.html" target="_blank">"Wirkungslose Antibiotika"</a> published in WirtschaftsWoche on June 23rd, 2014.</em></html>
| |
| | | | |
| | + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| | = Blog #15 - Noneffective Antibiotics (Part I): Dangerous Battle against Killer Germs = | | = Blog #15 - Noneffective Antibiotics (Part I): Dangerous Battle against Killer Germs = |
| | By [[User:NBailly|NBailly]] 17:06, June 23 2014 (CDT) | | By [[User:NBailly|NBailly]] 17:06, June 23 2014 (CDT) |
| | | | |
| - | Are we soon going to be dying of pneumonia again? The danger exists, because most pharma groups have neglected antibiotics research for decades – and now more and more drugs fail against the killer germs. | + | {{Team:Aachen/FigureFloat|Aachen_SEM_of_Pseudomonas_aeruginosa.jpg|width=400px|title= SEM of ''Pseudomonas aeruginosa''|subtitle=Picture by Janice Haney Carr.}} |
| | + | <html>Are we soon going to be dying of pneumonia again? It is almost unimaginable, but the danger that our antibiotics will soon fail against plagues thought to be conquered a long time ago, is eminent. In fact, the situation has grown very acute. The all-purpose weapon antibiotic is on the verge of losing its vigor since many pathogens, such as the pneumonia causing bacterium <i>Pseudomonas aeruginosa</i> , have become resistant. Experts of the World Health Organization (WHO) have already raised a loud alarm: In their recently published first <a href="http://www.who.int/drugresistance/documents/surveillancereport/en/" title="WHO Antimicrobial resistance: global report on surveillance 2014" target="_blank">global resistance report</a>, they are drawing a rather apocalyptic picture. If nothing is done, doctors soon might not be able to do anything but stand helplessly next to their patients while they are dying from nowadays easily curable diseases or even smallest wound infections.</html> [https://2014.igem.org/Team:Aachen/Blog/14-06-23-01 Read more...] |
| | | | |
| - | Ice cold fog is rising. Jochen Maas and Peter Hammann carefully pull out a drawer with hundreds of plastic tubes from the almost -200°C cold liquid nitrogen tank. What the two are lifting out of a kind of deep-frozen maximum security zone in the lab of the French-German pharma company Sanofi are microbes, party more than 100 years old. The round 120,000 fungal and bacterial strains are not only an invaluable treasure for the company. Primarily, they are a sort of life insurance for human kind against constantly emerging new forms of extremely aggressive life-threatening germs.
| |
| | | | |
| - | | + | {{Team:Aachen/BlockSeparator}} |
| - | <html><a style="text-align: center; display: block;" href="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/06/3-format27.jpg"><img class="size-full wp-image-238" src="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/06/3-format27.jpg" alt="The Sanonfi reseachers Hammann (left) and Maas want to draw new antibiotics from fungi and bacteria." width="740" height="417" /><figcaption>The Sanonfi reseachers Hammann (left) and Maas want to draw new antibiotics from fungi and bacteria.</figcaption></a></html>
| + | |
| - | | + | |
| - | | + | |
| - | Maas, research director of Sanofi Germany, and Hammann, who is responsible for innovation worldwide in the company, now want to retrieve this treasure. In collaboration with the Fraunhofer Institute for Molecular Biology and Applied Ecology in Gießen, they are looking for modern and highly effective against bacterial infections such as pneumonia or sepsis – for new antibiotics.
| + | |
| - | <html><div style="border: 1px solid black; padding: 1px;">
| + | |
| - | | + | |
| - | | + | |
| - | <strong>Tactics for the Correct Usage of Antibiotics</strong>
| + | |
| - | </br></br>
| + | |
| - | <em>How antibiotic resistances develop</em></br>
| + | |
| - | Bacteria change constantly in order to adapt to the varying environmental conditions. Small variations in the genetic makeup, the mutations, provide some microbes with an evolutionary advantage, that then proliferate more strongly than their conspecifics. This basic principle of evolution also helps pathogens to defend themselves against antibiotics, for example, by destroying the active ingredient before the latter is able to harm them. However, we can make it more difficult for germ to develop resistances by considering some tactics.
| + | |
| - | </br></br>
| + | |
| - | <em>Use antibiotics sparingly</em></br>
| + | |
| - | Even if it sounds trivial – only if a bacterium comes in contact with an antibiotic, the resistance gives it an evolutionary advantage. Therefore, doctors should prescribe the drug only when it is really necessary due to medical reasons. However, they still use antibiotics way too laxly and often. Even when they are no good: with colds, for example, that are mostly caused by viruses against which antibiotics are powerless. First rapid tests for family doctors already exist in order to discriminate viruses and bacteria.
| + | |
| - | On top of that, farmers have uses broad-spectrum antibiotics for decades as a mast agent in animal breeding, which is officially forbidden in the Europe. Of the 2000 tons of antibiotics used in Germany, only 350 tons are designated for human use, the rest for animals. Due to the constant contact with antibiotics, resistances in stables arise quickly that can be transferred to germs that also disease humans.
| + | |
| - | </br></br>
| + | |
| - | <em>Dose antibiotics correctly</em></br>
| + | |
| - | When a doctors prescribes an antibiotic, it must not be underdosed or the therapy stopped too soon. Otherwise, exactly those germs survive that have developed a defensive strategy. They then pass the resistances to their progeny.
| + | |
| - | </br></br>
| + | |
| - | <em>Disinfect thoroughly</em></br>
| + | |
| - | Hospitals are a sort of paradise for germs: The many existing pathogens can exchange resistances; old, immune deficient patients bring new germs into the house: each surgery opens an ideal entry path for the germs into the human body. Thus, scrupulous hygiene in clinics is extremely important. Meanwhile many institutions refuse to accept germ-infested patients from, for example, from poorly managed senior homes, or consequently send them to isolations wards.
| + | |
| - | </br></br>
| + | |
| - | <em>Diagnose Early</em></br>
| + | |
| - | Up to now, a doctor often does not know whether he should prescribe a broad-spectrum antibiotic early on, in order to kill many bacteria as quickly as possible, or whether he should rather specifically attack a single type of germ with a special remedy. Gene quick tests now make it possible to identify the pathogen before treatment. Before it took days.</div></html>
| + | |
| - | | + | |
| - | | + | |
| - | Numerous of such medical ingredients have emerged from this collection. But that was a long time ago. Like almost all pharma companies, Sanofi, too, had mostly abandoned antibiotics research. There were so many, meanwhile dirt-cheap, drugs against once deadly pestilences such as syphilis and tuberculosis or against everyday infections such an inflammation of the middle ear or bladder infection. Even more critical: Companies could make more money out of cardiac and cancer treatments, that patients have to take for years, than out of antibiotics. This is because the patient mostly takes antibiotics for a few days only to get healthy again.
| + | |
| - | | + | |
| - | <html>Meanwhile the situation has grown very acute. The all-purpose weapon antibiotic is on the verge of losing its vigor. Many pathogens have become resistant. Plagues long thought conquered come back. The experts at the World Health Organization (WHO) have already raised a loud alarm. In their recently published first <a href="http://www.who.int/drugresistance/documents/surveillancereport/en/" title="WHO Antimicrobial resistance: global report on surveillance 2014" target="_blank">global resistance report</a> they are portraying a rather apocalyptic picture. If nothing happens, doctors soon helplessly have to watch patients die of nowadays easily curable diseases or even the smallest wound infections.</html>
| + | |
| - | | + | |
| - | | + | |
| - | <html><a style="text-align: center; display: block;" href="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/06/2-format2101.jpg"><img class="size-full wp-image-236" src="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/06/2-format2101.jpg" alt="Harmless infections, deadly end: Long antibiotics seemed secure against dangerous disease. But now more and more bacteria world-wide are resistant. The World Health Organization warns against a new era." width="620" height="349" /><figcaption>Harmless infections, deadly end: Long antibiotics seemed secure against dangerous disease. But now more and more bacteria world-wide are resistant. The World Health Organization warns against a new era.</figcaption></a></html>
| + | |
| - | | + | |
| - | | + | |
| - | The circumstances are so extreme that even governments are investing in order to make germ defense palatable again for the pharma industry: The British pharma company GlaxoSmithKIine receives 200 million dollars from the US Ministry of Health in order to develop new resistance crushers in the upcoming five years. The European Union plans something similar with the program New Drugs for Bad Bugs.
| + | |
| - | | + | |
| - | Apart from Sanofi, other industry giants, such as Roche or Bayer, have made a face-turn and invest again in the fields of research that they had closed or demerged years ago. All of them now expect good business. In the face of this new state of emergency funds and patients at least in the wealthy part of the world are willing to pay a lot of money for effective antibiotics.
| + | |
| - | | + | |
| - | However, while it will take years until market-ready drugs arise from the now kicked off research projects of the industry giants, some few pharma and biotech companies that unperturbedly did their research, are already one step ahead. They are now already up with new or pre-commercial drugs. Big hopes rest on them now because it will depend on these new remedies whether mankind in the 21st century will not give way again to the disease-causing bacteria.
| + | |
| - | | + | |
| - | | + | |
| - | <html><em>A translation of <a href="http://www.wiwo.de/technologie/forschung/wirkungslose-antibiotika-gefaehrlicher-kampf-gegen-killerkeime/10076108.html" target="_blank">"Wirkungslose Antibiotika"</a> published in WirtschaftsWoche on June 23rd, 2014.</em></html>
| + | |
| | | | |
| | = Blog #14 - Students Explore Careers in Synthetic Biology = | | = Blog #14 - Students Explore Careers in Synthetic Biology = |
| | By [[User:NBailly|NBailly]] 21:11, June 12 2014 (CDT) | | By [[User:NBailly|NBailly]] 21:11, June 12 2014 (CDT) |
| | + | |
| | + | {{Team:Aachen/FigureFloat|Cellock_liegend.png|left|width=300px}} |
| | | | |
| | Our "Synthetic Biology" teaching module has come to an end. Today was our last day at Kaiser-Karl-Gymnasium in Aachen, where we have worked together with a grade 9 biology-chemistry class for past 1 1/2 months. <!--more-->The students have learned about the iGEM and synthetic biology in general. We presented our project to the class, and explained various aspects for our endeavour in more detail. | | Our "Synthetic Biology" teaching module has come to an end. Today was our last day at Kaiser-Karl-Gymnasium in Aachen, where we have worked together with a grade 9 biology-chemistry class for past 1 1/2 months. <!--more-->The students have learned about the iGEM and synthetic biology in general. We presented our project to the class, and explained various aspects for our endeavour in more detail. |
| | | | |
| - | To give interested students some overview of how they can get involved in synthetic biology, Vera, Florian, Ansgar and Björn gave short presentations about each university program at RWTH represented in our team: Biology, Biotechnology, Computational Engineering Science and Informatics, respectively. We gave them examples for typical classes and specialization options as well as career perspectives in each program. | + | To give interested students some overview of how they can get involved in synthetic biology, Vera, Florian, Ansgar and Björn gave short presentations about each university program at RWTH represented in our team. [https://2014.igem.org/Team:Aachen/Blog/14-06-12-01 Read more...] |
| - | | + | |
| - | <html><a style="text-align: center; display: block;" href="https://2014.igem.org/File:Cellock_liegend.png"><img class="size-medium wp-image-218" src="https://static.igem.org/mediawiki/2014/b/ba/Cellock_liegend.png" alt="cellock_liegend" width="300" height="194" /></a></html>
| + | |
| - | | + | |
| - | While discussing some more career perspectives, we handed an evaluation sheet out to each student. This way the class could give us some feedback about our work, and leave some comments on what they liked best and what we can still improve on. On average, the students gave us an A (1,9 or 87%) for the teaching module. We are really happy about this great mark, and will try to improve on all the things the students suggested.
| + | |
| - | | + | |
| - | Unfortunately, the bell already rang when the students finished handing in their evaluation sheets. However, some students still followed our invitation to stay after class to ask more questions about paths into synthetic biology, and for some cookies.
| + | |
| | | | |
| - | Overall, all parties seemed really satisfied with our collaboration and we are looking forward to repeating the teaching module with other high school classes!
| |
| | | | |
| | + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| | = Blog #13 - Teaching Module Wrap-Up = | | = Blog #13 - Teaching Module Wrap-Up = |
| | By [[User:NBailly|NBailly]] 16:32, June 05 2014 (CDT) | | By [[User:NBailly|NBailly]] 16:32, June 05 2014 (CDT) |
| | | | |
| - | Today Nina and Arne discussed last class's experiment. Arne explained to the students the meaning behind the values measured, and how the students can use the value to determine the concentration of riboflavin in their vanilla pudding samples. | + | Today [[User:NBailly|Nina]] and [[User:AZimmermann|Arne]] discussed last class's experiment. Arne explained to the students the meaning behind the values measured, and how the students can use the value to determine the concentration of riboflavin in their vanilla pudding samples. [https://2014.igem.org/Team:Aachen/Blog/14-06-05-01 Read more...] |
| | | | |
| - | <html><a style="text-align: center; display: block;" href="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/04/cellock_stehend.png"><img src="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/04/cellock_stehend-268x300.png" alt="cellock_stehend" width="268" height="300" class="aligncenter size-medium wp-image-194" /></a></html>
| + | [[File:Cellock_stehend.png|center|300px|frameless]] |
| | | | |
| - | Subsequently, Nina explained the students how we are going to manipulate regular E. coli cells, using synthetic biology methods, to carry out the desired functions. The students also learned, what role promoters play in gene regulation, and how our iGEM team wants to regulate the expression of the genes artificially inserted into the E. coli cells.
| |
| | | | |
| - | Now we have individually discussed all aspects of our project. Therefore, Nina summarized all the topic together with the students, and outlined the link between all these different topics and our iGEM project idea. In doing so, we almost arrived at the end of our teaching module "Synthetic Biology". Next class, we will visit the biology-chemistry course of Kaiser-Karl-Gymnasium for the last time, and do some career-exploration in synthetic biology and related fields.
| + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| | = Blog #12 - Glowing vanilla pudding = | | = Blog #12 - Glowing vanilla pudding = |
| | By [[User:NBailly|NBailly]] 16:16, June 02 2014 (CDT) | | By [[User:NBailly|NBailly]] 16:16, June 02 2014 (CDT) |
| | | | |
| - | The topics of today's double lesson was quorum sensing as well as measurement of fluorescence. At the beginning of class, the students form 6 groups and start an experiment dealing with fluorescence: Each group weighs and dissolves 4g of vanilla pudding powder in 50mL of water. While conducting the experiment, each group is supervised by a member of our iGEM team. | + | {{Team:Aachen/FigureFloat|Aachen KKG (15).jpg|left|width=300px|title=Our iGEM stand|subtitle=Things needed for a cool experiment.}} |
| | + | The topics of today's double lesson was quorum sensing as well as measurement of fluorescence. At the beginning of class, the students form 6 groups and start an experiment dealing with fluorescence: Each group weighs and dissolves 4g of vanilla pudding powder in 50mL of water. While conducting the experiment, each group is supervised by a member of our iGEM team. [https://2014.igem.org/Team:Aachen/Blog/14-06-02-01 Read more...] |
| | | | |
| - | <html><a style="text-align: center; display: block;" href="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/06/10435248_641110302633096_1365222319_o.jpg"><img src="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/06/10435248_641110302633096_1365222319_o-1024x682.jpg" alt="Vanillepudding 1" width="590" height="392" class="aligncenter size-large wp-image-184" /></a></html>
| |
| | | | |
| - | While we give the powder some time to dissolve, René discusses the worksheet about quorum sensing that we gave out to the students last week. In doing so, the students learn what quorum sensing actually is, how it is used in different ways by a variety of bacteria, and how we want to use this function for our project.
| + | {{Team:Aachen/BlockSeparator}} |
| - | | + | |
| - | <html><a style="text-align: center; display: block;" href="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/06/10371107_641111112633015_62538188_o.jpg"><img src="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/06/10371107_641111112633015_62538188_o-1024x682.jpg" alt="Quorum Sensing Folie" width="590" height="392" class="aligncenter size-large wp-image-186" /></a></html>
| + | |
| - | | + | |
| - | Meanwhile the powder had dissolved in the water. Excess powder accumulated at the bottom of the beaker. Using a syringe, the students suck 2mL of supernatant out of the beaker, and press it through a filter into a cuvette. A part of our project involves the development of a fluorescence measurement device named "Cellock Holmes". Each group of students at a time places its cuvette in the "Cellock Holmes" prototype, and notes down the values displayed on the cellphone display. Of course, each group also measures the fluorescence of a positive (pure riboflavin in water) and a negative (chalk dust in water) control.
| + | |
| - | | + | |
| - | <html><a style="text-align: center; display: block;" href="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/06/10172978_641110589299734_1681172065_o.jpg"><img src="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/06/10172978_641110589299734_1681172065_o-1024x682.jpg" alt="Measuring with Cellock Holmes" width="590" height="392" class="aligncenter size-large wp-image-187" /></a></html>
| + | |
| - | | + | |
| - | While the other groups wait for their turn, their supervisors explain the background of this experiment: The electrons in some molecules change into energy states when irradiated with electromagnetic waves. When returning to the normal state, the electrons dissipate excess energy, also in the form of electromagnetic radiation. This process is called fluorescence. Vanilla pudding contains the molecule riboflavin (vitamin B2). When riboflavin is irradiated with blue light, the molecule fluoresces green. The intensity of the green light is visually recorded by our device. Special software processes the data and the measured value is displayed on the cellphone connected to the device via Bluetooth. We will discuss the results of the experiment next class.
| + | |
| | | | |
| | = Blog #11 - No time for high politics = | | = Blog #11 - No time for high politics = |
| - | By [[User:NBailly|NBailly]] 15:42, May 30 2014 (CDT) | + | By [[User:NBailly|NBailly]] 15:42, May 31 2014 (CDT) |
| | | | |
| | + | {{Team:Aachen/FigureFloat|Aachen HuClimateUN.jpg|width=300px|title=UN Climate Change Conference|subtitle=Summits like the UN Climate Change Conference are the wrong approach to problems such as antibiotic resistances, says Lars Fischer. Picture from the Intern Blog of American University.}} |
| | International collaborations against antibiotic resistances are all well and good, but the UN Climate Change conference of all collaborations shows why coordination at the government level is the wrong approach, says Lars Fischer, editorial journalist at "Spektrum Der Wissenschaft". | | International collaborations against antibiotic resistances are all well and good, but the UN Climate Change conference of all collaborations shows why coordination at the government level is the wrong approach, says Lars Fischer, editorial journalist at "Spektrum Der Wissenschaft". |
| | + | Not even a century ago, the discovery of antibiotics caused a decisive turn for the better in the millennia-long battle against infectious diseases. But while many already saw pathogenic agents eradicated and a golden age of medicine seemed within reach, we have now however reached an abyss: a dramatic relapse into a world looms ahead, where microorganisms are again rulers over life and death. |
| | | | |
| | + | The threat emanating from the increasing antibiotic resistances is existential—for every one of us, as well as the countries and society itself. That the world community unites in a supranational board in order to face the latter, suggests itself. However, as alluring as the vision of an intergovernmental panel on antimicrobial resistance may be, as evoked by Mark Woolhouse and Jeremy Farrar (authors of the Nature article "Policy: An intergovernmental panel on antimicrobial resistance", published May 2014), this thought is gravely mistaken. [https://2014.igem.org/Team:Aachen/Blog/14-05-31-01 Read more...] |
| | | | |
| - | <html><a style="text-align: center; display: block;" href="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/05/AB1.jpg"><img src="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/05/AB1.jpg" alt="Unregulated sales of medicines in developing countries contribute to the rise in antimicrobial resistance. Photo by ISSOUF SANOGO/AFP/Getty" width="400" height="273" class="size-full wp-image-199" /><figcaption> </figcaption>Unregulated sales of medicines in developing countries contribute to the rise in antimicrobial resistance. Photo by ISSOUF SANOGO/AFP/Getty</a></html>
| |
| | | | |
| - | | + | {{Team:Aachen/BlockSeparator}} |
| - | Not even a century ago, the discovery of antibiotics caused a decisive turn for the better in the millennia-long battle against infectious diseases. But while many already saw pathogenic agents eradicated and a golden age of medicine seemed in reach, we have now reached an abyss: a dramatic relapse into a world looms, where microorganisms are again rulers over life and death.
| + | |
| - | | + | |
| - | The threat emanating from the increasing antibiotic resistances is existential; for every one of us, as well as the countries and society itself. That the world community unites in a supranational board in order to face the latter, suggests itself. However, as alluring as the vision of an intergovernmental panel on antimicrobial resistance, as evoked by Mark Woolhouse and Jeremy Farrar (authors of the Nature article "Policy: An intergovernmental panel on antimicrobial resistance", published May 2014), may be, this thought is gravely mistaken.
| + | |
| - | | + | |
| - | Indeed, it is right that there are parallels between climate change and antibiotic resistances, however, there are also extensive–essential–differences. Firstly, the time span: Glaciers melt over centuries, climate zones shift over centuries, the ocean level rises over millennia. That frame is very suited for the international wrestling with measures and agreements, one that often reminds outsiders of a geological process. The first bacterial resistances against a new antibiotic currently appear within a few years.
| + | |
| - | | + | |
| - | | + | |
| - | <html><a style="text-align: center; display: block;" href="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/05/MRSA-bacteria.jpg.1434678.jpg"><img src="http://igem.rwth-aachen.de/wordpress/wp-content/uploads/2014/05/MRSA-bacteria.jpg.1434678.jpg" alt="The scanning electron micrograph shows the spherical cells of MRSA bacteria (yellow) and their escape from the human immune cells (red). © NIAID / CC-by-2.0 (CC BY) " width="400" height="381" class="size-full wp-image-198" /><figcaption>The scanning electron micrograph shows the shperical cells of MRSA bacteria (yellow) and their escape from the human immune cells (red). © NIAID / CC-by-2.0 (CC BY)</figcaption></a></html>
| + | |
| - | | + | |
| - | | + | |
| - | And the case of climate change is still quite simple because there is an actual scientific consensus that can be recommended to politics. Regarding antibiotic resistances, it is way more complicated. Data is lacking everywhere. The only thing that a panel like that could agree on at this moment would be a substantial need for research.
| + | |
| - | | + | |
| - | This would be a fatal signal for practice: First a big multinational panel is founded that is supposed to recommend the ultimate measures against antibiotic resistances, and then the organisation can hardly say more than "The facts are yet to be established". There is a great danger, that most stakeholders would first wait until the panel sees through its decision. And subsequently, one would still have to consolidate these recommendations at the governmental level–recommendations whose data basis is necessarily thin and incomplete. It would be easy for the profiteers of the status quo to thwart such an endeavour–just like it is happening with climate change.
| + | |
| - | | + | |
| - | Therefore, the combatants of resistances should rather avoid big politics and use the already-established networks to coordinate themselves internationally. If in doubt, influence on politics and corporations should be looked for on a local level. There are–as Woolhouse and Farrar wrote themselves–a multitude of examples for regional organisations and initiatives. Of course, such sectioned measurement structures have their disadvantages, but they are by far implemented more quickly. And the time factor is crucial: A race with bacteria has to be approached differently from one with glaciers.
| + | |
| - | | + | |
| - | | + | |
| - | | + | |
| - | <html><em>A translation of <a href="http://www.spektrum.de/news/keine-zeit-fuer-hohe-politik/1288099" target="_blank">"Keine Zeit für hohe Politik"</a> published in "Spektrum der Wissenschaft" on May 30th, 2014.</em></html>
| + | |
| | | | |
| | = Blog #10 - Microorganisms on the rise = | | = Blog #10 - Microorganisms on the rise = |
| | By [[User:NBailly|NBailly]] 16:05, May 26 2014 (CDT) | | By [[User:NBailly|NBailly]] 16:05, May 26 2014 (CDT) |
| | | | |
| - | Last lesson students at Kaiser-Karl-Gymnasium took environmental samples using a variety of different contact agar plates. On the weekend, René examined the plates under the microscope and took photos. Today René and Nina present the students the results of the experiment.<!--more--> But first, we showed the students an excerpt from the TV show "Planetopia" that broaches the issue "Hygiene in every-day life".
| + | {{Team:Aachen/FigureFloat|10404745_641111075966352_965198584_o.jpg|right|width=200px}} |
| - | | + | |
| - | [[File:10404745_641111075966352_965198584_o.jpg|800px]]
| + | |
| | | | |
| - | [[File:14-05-25_Fotos_Versuchsergebnisse_(12_14).jpg|800px]] | + | Last lesson students at Kaiser-Karl-Gymnasium took environmental samples using a variety of different contact agar plates. On the weekend, René examined the plates under the microscope and took photos. Today [[User:R.hanke|René]] and [[User:NBailly|Nina]] present the students the results of the experiment.<!--more--> But first, we showed the students an excerpt from the TV show "Planetopia" that broaches the issue "Hygiene in every-day life". [https://2014.igem.org/Team:Aachen/Blog/14-05-26-01 Read more...] |
| | | | |
| - | <em>Staphylo-</em> and <em>micrococci</em> as well as <em>Enterobacteria</em>, <em>Candida</em> yeasts and miscellaneous fungi are found on the majority of plates. But why is there no growth on the plates containing the antibiotic? Actually, what is an antibiotic, how does it work and why are there multi-resistant pathogens? Nina explained the answer to all these questions to the students using descriptive graphics, and concluded the topic "Microorganisms in our Environment" with a short summmary.
| |
| | | | |
| - | As a starter for our next topic that is relevant to our project, we distribute a worksheet about quorum sensing among the students. For the remainder of the lesson, the students read the text and begin to answer the attached questions.
| + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| | = Blog #9 - Going to Munich = | | = Blog #9 - Going to Munich = |
| Line 286: |
Line 135: |
| | Hello iGEM enthusiasts, | | Hello iGEM enthusiasts, |
| | | | |
| - | on the coming weekend 3 of our team (Markus, Michael and Arne) are going to travel to Munich for the iGEM meetup iGEM meets CAS. We are very excited for this and can’t wait to meet all the other teams who will be attending. Stay tuned to this blog to see the first pictures when we come back! | + | on the coming weekend 3 of our team ([[User:Mjoppich|Markus]], [[User:Mosthege|Michael]] and [[User:AZimmermann|Arne]]) are going to travel to Munich for the iGEM meetup iGEM meets CAS. We are very excited for this and can’t wait to meet all the other teams who will be attending. Stay tuned to this blog to see the first pictures when we come back! |
| | | | |
| | So stay tuned! | | So stay tuned! |
| | + | |
| | + | |
| | + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| | = Blog #8 - iGEM team members back 2 school = | | = Blog #8 - iGEM team members back 2 school = |
| | By [[User:NBailly|NBailly]] 16:00, May 22 2014 (CDT) | | By [[User:NBailly|NBailly]] 16:00, May 22 2014 (CDT) |
| | + | |
| | + | {{Team:Aachen/FigureFloat|Aachen_Kaiser-Karls-Gymnasium.jpg|right|width=200px}} |
| | | | |
| | Hello iGEM enthusiasts, | | Hello iGEM enthusiasts, |
| | Since our last visit, the student of the biology-chemistry course at Kaiser-Karl-Gymnasium in Aachen have been busy studying the basics of protein biosynthesis and the "lock and key" model. Now the 9th graders are prepared to have a closer look at synthetic biology and our project. | | Since our last visit, the student of the biology-chemistry course at Kaiser-Karl-Gymnasium in Aachen have been busy studying the basics of protein biosynthesis and the "lock and key" model. Now the 9th graders are prepared to have a closer look at synthetic biology and our project. |
| | | | |
| - | [[File:Aachen_Kaiser-Karls-Gymnasium.jpg|800px]] | + | [https://2014.igem.org/Team:Aachen/Blog/14-05-22-01 Read more...] |
| | | | |
| - | Each year, many people die of nosocominal infections - infections that the patients acquired in a hospital. However, these infections would be preventable in large part through better hygiene programs. Diseases caused by multi-resistant pathogens are especially critical because therapy options are very limited in these cases.
| |
| - |
| |
| - | But actually, what are pathogens exactly and where do they come from? In order to answer these questions, we start the teaching module with the topic "Microorganisms in our Environment". In this part, we explain which germs we encounter every day, and how be can best protect ourselves from them.
| |
| - |
| |
| - | In order to demonstrate how many and which microorganisms are our steady companions, we conduct an experiment with the students. A pair of students received 3 agar plates: one with regular LB agar, one plate with agar supplemented by an antibiotic, and one selective agar plate for yeasts and fungi. Equipped with the plates, the students wander through their school and take contact samples from places they think many microorganisms grow there. We will incubate the plates over the weekend so that we can show the students in the next lesson what has grown on their samples.
| |
| | | | |
| | + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| | = Blog #7 - The Biobricks have arrived = | | = Blog #7 - The Biobricks have arrived = |
| | By [[User:AZimmermann|AZimmermann]] 16:02, May 12 2014 (CDT) | | By [[User:AZimmermann|AZimmermann]] 16:02, May 12 2014 (CDT) |
| | + | |
| | + | {{Team:Aachen/FigureFloat|Aachen_Biobricks_arrival_2014.jpg|left|width=300px}} |
| | | | |
| | Hello iGEM enthusiasts, | | Hello iGEM enthusiasts, |
| - |
| |
| - |
| |
| | we have finally gotten the iGEM 2014 biobricks! | | we have finally gotten the iGEM 2014 biobricks! |
| - |
| |
| - | [[File:Aachen_Biobricks_arrival_2014.jpg|400px]]
| |
| - |
| |
| - |
| |
| | Now we can really start working on the molecular side of our project. | | Now we can really start working on the molecular side of our project. |
| | | | |
| Line 323: |
Line 169: |
| | So stay tuned! | | So stay tuned! |
| | | | |
| | + | |
| | + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| | = Blog #6 - Preparing Cool Experiments = | | = Blog #6 - Preparing Cool Experiments = |
| Line 337: |
Line 185: |
| | }); | | }); |
| | </script> | | </script> |
| - | <div id="page" style="margin-left: auto; margin-right: auto; position: relative; height: 610px; width: 460px; border-radius: 10px; border-color: #8ebae5; background: none repeat scroll 0% 0% #8ebae5;"> | + | <div id="page" style="margin-left: auto; margin-right: auto; position: relative; height: 610px; width: 460px; border-radius: 10px; border-color: #8ebae5; background: none repeat scroll 0% 0% #8ebae5; z-index:0;"> |
| | <div id="content" style="top: 50%; left: 50%; margin: -300px 0px 0px -230px; position: absolute"> | | <div id="content" style="top: 50%; left: 50%; margin: -300px 0px 0px -230px; position: absolute"> |
| | <div class="border_box"> | | <div class="border_box"> |
| Line 352: |
Line 200: |
| | </div> | | </div> |
| | </html> | | </html> |
| | + | |
| | + | |
| | + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| | = Blog #5 - Assembly in progress = | | = Blog #5 - Assembly in progress = |
| Line 365: |
Line 216: |
| | <script type="text/javascript" language="javascript"> | | <script type="text/javascript" language="javascript"> |
| | $(document).ready(function(){ | | $(document).ready(function(){ |
| - | $('.box_skitter_large_blog_5').css({width: 760, height: 570}).skitter({animation: 'fade', label: false, numbers: true, numbers_align: 'right', auto_play: true, controls: true, controls_position: 'rightBottom' , navigation: false , interval: 2500, theme: 'clean'}); | + | $('.box_skitter_large_blog_5').css({width: 780, height: 580}).skitter({animation: 'fade', label: false, numbers: true, numbers_align: 'right', auto_play: true, controls: true, controls_position: 'rightBottom' , navigation: false , interval: 2500, theme: 'clean'}); |
| | }); | | }); |
| | </script> | | </script> |
| - | <div id="page" style="margin-left: auto; margin-right: auto; position: relative; height: 580px; width: 770px; border-radius: 10px; border-color: #8ebae5; background: none repeat scroll 0% 0% #8ebae5;"> | + | <div id="page" style="margin-left: auto; margin-right: auto; position: relative; height: 590px; width: 790px; border-radius: 10px; border-color: #8ebae5; background: none repeat scroll 0% 0% #8ebae5; z-index:0;"> |
| - | <div id="content" style="top: 50%; left: 50%; margin: -285px 0px 0px -385px; position: absolute"> | + | <div id="content" style="top: 50%; left: 50%; margin: -290px 0px 0px -395px; position: absolute"> |
| | <div class="border_box"> | | <div class="border_box"> |
| | <div class="box_skitter box_skitter_large_blog_5"> | | <div class="box_skitter box_skitter_large_blog_5"> |
| | <ul> | | <ul> |
| - | <li><a><img src="https://static.igem.org/mediawiki/2014/2/2b/Aachen_Device_Building_1_1.JPG/780px-Aachen_Device_Building_1_1.JPG"/></a><div class="label_text"><p>Hier Text möglich</p></div></li> | + | <li><a><img src="https://static.igem.org/mediawiki/2014 /thumb/2/2b/Aachen_Device_Building_1_1.JPG/780px-Aachen_Device_Building_1_1.JPG"/></a><div class="label_text"><p>Hier Text möglich</p></div></li> |
| - | <li><a><img src="https://static.igem.org/mediawiki/2014/e/e8/Aachen_device_building_1_2.JPG "/></a><div class="label_text"><p>Hier Text möglich</p></div></li> | + | <li><a><img src="https://static.igem.org/mediawiki/2014 /thumb/e/e8/Aachen_device_building_1_2.JPG/ 780px-Aachen_device_building_1_2.JPG"></a><div class="label_text"><p>Hier Text möglich</p></div></li> |
| - | <li><a><img src="https://static.igem.org/mediawiki/2014/6/60/Aachen_device_building_1_3.JPG "/></a><div class="label_text"><p>Hier Text möglich</p></div></li> | + | <li><a><img src="https://static.igem.org/mediawiki/2014 /thumb/6/60/Aachen_device_building_1_3.JPG/ 780px-Aachen_device_building_1_3.JPG"></a><div class="label_text"><p>Hier Text möglich</p></div></li> |
| - | <li><a><img src="https://static.igem.org/mediawiki/2014/8/80/Aachen_device_building_1_4.JPG "/></a><div class="label_text"><p>Hier Text möglich</p></div></li> | + | <li><a><img src="https://static.igem.org/mediawiki/2014 /thumb/8/80/Aachen_device_building_1_4.JPG/ 780px-Aachen_device_building_1_4.JPG"></a><div class="label_text"><p>Hier Text möglich</p></div></li> |
| | </ul> | | </ul> |
| | </div> | | </div> |
| Line 383: |
Line 234: |
| | </div> | | </div> |
| | </html> | | </html> |
| | + | |
| | + | |
| | + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| | = Blog #4 - We are approved! = | | = Blog #4 - We are approved! = |
| | By [[User:AZimmermann|AZimmermann]] 11:00, May 4 2014 (CDT) | | By [[User:AZimmermann|AZimmermann]] 11:00, May 4 2014 (CDT) |
| | | | |
| | + | {{Team:Aachen/Figure|Aachen_NEB_Kit_Arrival.jpg|width=400px|title= Also in this blog...|subtitle=NEB is awesome!}} |
| | Hello iGEM enthusiasts, | | Hello iGEM enthusiasts, |
| | | | |
| - | we are more than happy to finally be able to announce that our application has been finally approved by the iGEM headquarters. Now nothing will stand between us and our journey towards the giant Jamboree at the end of October! | + | we are more than happy to finally be able to announce that our application has been finally approved by the iGEM headquarters. Now nothing will stand between us and our journey towards the giant Jamboree at the end of October! |
| | | | |
| - | This will bring a few changes towards especially this site. With the approval we now have access to our own wiki website hosted on the iGEM servers. We will migrate all our previous content towards this site in the next weeks. This will include everyhting already posted on here. As soon as we have finished preparing the full migration you will automatically be redirected, so you do not need to remember a different website for all your IGEM Aachen information.
| + | [https://2014.igem.org/Team:Aachen/Blog/14-05-04-01 Read more...] |
| | | | |
| - | As soon as the migrations has been completed you will also find all the details you need to know about our project we have been teasing about the past weeks on facebook and twitter. So stay tuned!
| |
| - |
| |
| - | The project has been progressing nicely in part due to the awesome iGEM Kits provided by NEB:
| |
| - |
| |
| - | [[File:Aachen_NEB_Kit_Arrival.jpg|400px]]
| |
| - |
| |
| - | NEB you are awesome!
| |
| - |
| |
| - | Also as always you can follow us on
| |
| - | [http://www.facebook.com/iGEMAachen Facebook]] or [http://twitter.com/igemaachen Twitter]]for more information and a look behind the scenes.
| |
| | | | |
| | + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| | = Blog #3 - School Project Kick-Off = | | = Blog #3 - School Project Kick-Off = |
| Line 411: |
Line 257: |
| | In the upcoming weeks, exciting school lessons with members of our iGEM team await the students of the 9th grade biology-chemistry class. Different aspects of our project will be highlighted and explained to the students. Demonstrative experiments will explain the practical relevance. | | In the upcoming weeks, exciting school lessons with members of our iGEM team await the students of the 9th grade biology-chemistry class. Different aspects of our project will be highlighted and explained to the students. Demonstrative experiments will explain the practical relevance. |
| | | | |
| - | In today's lesson, our members Nina and René offered the students a short impression of what to expect in the course of this teaching module. We also explained synthetic biology and the goal of our project. | + | In today's lesson, our members [[User:NBailly|Nina]] and [[User:R.hanke|René]] offered the students a short impression of what to expect in the course of this teaching module. We also explained synthetic biology and the goal of our project. |
| | + | |
| | | | |
| | + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| | = Blog #2 - The box is opened = | | = Blog #2 - The box is opened = |
| Line 427: |
Line 275: |
| | }); | | }); |
| | </script> | | </script> |
| - | <div id="page" style="margin-left: auto; margin-right: auto; position: relative; height: 590px; width: 790px; border-radius: 10px; border-color: #8ebae5; background: none repeat scroll 0% 0% #8ebae5;"> | + | <div id="page" style="margin-left: auto; margin-right: auto; position: relative; height: 590px; width: 790px; border-radius: 10px; border-color: #8ebae5; background: none repeat scroll 0% 0% #8ebae5; z-index:0;"> |
| | <div id="content" style="top: 50%; left: 50%; margin: -290px 0px 0px -395px; position: absolute"> | | <div id="content" style="top: 50%; left: 50%; margin: -290px 0px 0px -395px; position: absolute"> |
| | <div class="border_box"> | | <div class="border_box"> |
| Line 444: |
Line 292: |
| | Guess what we are building? | | Guess what we are building? |
| | | | |
| | + | |
| | + | {{Team:Aachen/BlockSeparator}} |
| | | | |
| | = Blog #1 - The opening = | | = Blog #1 - The opening = |
| | By [[User:AZimmermann|AZimmermann]] 10:31, April 24 2014 (CDT) | | By [[User:AZimmermann|AZimmermann]] 10:31, April 24 2014 (CDT) |
| | | | |
| - | [[File:Aachen_Opening_Arduino_Box.jpg|250px]]
| + | {{Team:Aachen/FigureFloat|Aachen_Opening_Arduino_Box.jpg|width=250px}} |
| - | | + | |
| | Hello everyone, | | Hello everyone, |
| | the iGEM competition has officially started and we are taking part! | | the iGEM competition has officially started and we are taking part! |
| Line 459: |
Line 308: |
| | This year Aachen is rocking iGEM! | | This year Aachen is rocking iGEM! |
| | | | |
| - | {{Team:Aachen/SlimFooter}} | + | {{Team:Aachen/Footer}} |
"
.JPG)
.jpg)
